Breaking News

Avacta Appoints Chief Development Officer

Neil Bell brings 30 years’ experience in the drug development industry.

By: Contract Pharma

Contract Pharma Staff

Avacta Group plc, the developer of Affimer biotherapeutics and reagents, has appointed Neil Bell as chief development officer of Avacta Life Sciences with immediate effect. Bell will be responsible for late stage pre-clinical and early clinical development of Avacta’s pipeline of pre|CISION pro-drugs and Affimer immunotherapies.   Bell has over 30 years’ experience in the drug development industry, having held senior positions in global pharmaceutical companies and innovative biotechs. Most rece...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters